A dual role for TGF-β1 in the control and persistence of fungal pneumonia

Xiuping Shao, Johanna Rivera, Ramata Niang, Arturo Casadevall, David L. Goldman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

TGF-β1 (TGF) has been implicated in the pathogenesis of several chronic infections and is thought to promote microbial persistence by interfering with macrophage function. In rats with experimental pulmonary cryptococcosis, increased lung levels of TGF were present at 12 mo of infection. Within the lung, expression of TGF localized to epithelioid cells and foamy macrophages in areas of inflammation. Increased TGF expression was also observed in the lungs of experimentally infected mice and a patient with pulmonary cryptococcosis. TGF reduced Ab and serum-mediated phagocytosis of Cryptococcus neoformans by rat alveolar macrophages (AM) and peripheral blood monocytes, and this was associated with decreased chemokine production and oxidative burst. Interestingly, TGF-treated rat AM limited both intracellular and extracellular growth of C. neoformans. Control of C. neoformans growth by TGF-treated rat AM was due to increased secretion of lysozyine, a protein with potent antifungal activity. The effects of TGF on the course of infection were dependent on the timing of TGF administration relative to the time of infection. TGF treatment of chronically infected rats resulted in reduced lung fungal burden, while treatment early in the course of infection resulted in increased fungal burden. In summary, our studies suggest a dual role for TGF in persistent fungal pneumonia whereby it contributes to the local control of infection by enhancing macrophage antifungal efficacy through increased lysozyme secretion, while limiting inflammation by inhibiting macrophage/monocyte phagocytosis and reducing associated chemokine production and oxidative burst.

Original languageEnglish (US)
Pages (from-to)6757-6763
Number of pages7
JournalJournal of Immunology
Volume175
Issue number10
StatePublished - Nov 15 2005

Fingerprint

Pneumonia
Lung
Cryptococcus neoformans
Alveolar Macrophages
Macrophages
Cryptococcosis
Infection
Respiratory Burst
Phagocytosis
Chemokines
Monocytes
Inflammation
Epithelioid Cells
Muramidase
Infection Control
Growth
Therapeutics
Serum
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

A dual role for TGF-β1 in the control and persistence of fungal pneumonia. / Shao, Xiuping; Rivera, Johanna; Niang, Ramata; Casadevall, Arturo; Goldman, David L.

In: Journal of Immunology, Vol. 175, No. 10, 15.11.2005, p. 6757-6763.

Research output: Contribution to journalArticle

Shao, Xiuping ; Rivera, Johanna ; Niang, Ramata ; Casadevall, Arturo ; Goldman, David L. / A dual role for TGF-β1 in the control and persistence of fungal pneumonia. In: Journal of Immunology. 2005 ; Vol. 175, No. 10. pp. 6757-6763.
@article{380e4d4b985743ea87f8f7ce971c7919,
title = "A dual role for TGF-β1 in the control and persistence of fungal pneumonia",
abstract = "TGF-β1 (TGF) has been implicated in the pathogenesis of several chronic infections and is thought to promote microbial persistence by interfering with macrophage function. In rats with experimental pulmonary cryptococcosis, increased lung levels of TGF were present at 12 mo of infection. Within the lung, expression of TGF localized to epithelioid cells and foamy macrophages in areas of inflammation. Increased TGF expression was also observed in the lungs of experimentally infected mice and a patient with pulmonary cryptococcosis. TGF reduced Ab and serum-mediated phagocytosis of Cryptococcus neoformans by rat alveolar macrophages (AM) and peripheral blood monocytes, and this was associated with decreased chemokine production and oxidative burst. Interestingly, TGF-treated rat AM limited both intracellular and extracellular growth of C. neoformans. Control of C. neoformans growth by TGF-treated rat AM was due to increased secretion of lysozyine, a protein with potent antifungal activity. The effects of TGF on the course of infection were dependent on the timing of TGF administration relative to the time of infection. TGF treatment of chronically infected rats resulted in reduced lung fungal burden, while treatment early in the course of infection resulted in increased fungal burden. In summary, our studies suggest a dual role for TGF in persistent fungal pneumonia whereby it contributes to the local control of infection by enhancing macrophage antifungal efficacy through increased lysozyme secretion, while limiting inflammation by inhibiting macrophage/monocyte phagocytosis and reducing associated chemokine production and oxidative burst.",
author = "Xiuping Shao and Johanna Rivera and Ramata Niang and Arturo Casadevall and Goldman, {David L.}",
year = "2005",
month = "11",
day = "15",
language = "English (US)",
volume = "175",
pages = "6757--6763",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - A dual role for TGF-β1 in the control and persistence of fungal pneumonia

AU - Shao, Xiuping

AU - Rivera, Johanna

AU - Niang, Ramata

AU - Casadevall, Arturo

AU - Goldman, David L.

PY - 2005/11/15

Y1 - 2005/11/15

N2 - TGF-β1 (TGF) has been implicated in the pathogenesis of several chronic infections and is thought to promote microbial persistence by interfering with macrophage function. In rats with experimental pulmonary cryptococcosis, increased lung levels of TGF were present at 12 mo of infection. Within the lung, expression of TGF localized to epithelioid cells and foamy macrophages in areas of inflammation. Increased TGF expression was also observed in the lungs of experimentally infected mice and a patient with pulmonary cryptococcosis. TGF reduced Ab and serum-mediated phagocytosis of Cryptococcus neoformans by rat alveolar macrophages (AM) and peripheral blood monocytes, and this was associated with decreased chemokine production and oxidative burst. Interestingly, TGF-treated rat AM limited both intracellular and extracellular growth of C. neoformans. Control of C. neoformans growth by TGF-treated rat AM was due to increased secretion of lysozyine, a protein with potent antifungal activity. The effects of TGF on the course of infection were dependent on the timing of TGF administration relative to the time of infection. TGF treatment of chronically infected rats resulted in reduced lung fungal burden, while treatment early in the course of infection resulted in increased fungal burden. In summary, our studies suggest a dual role for TGF in persistent fungal pneumonia whereby it contributes to the local control of infection by enhancing macrophage antifungal efficacy through increased lysozyme secretion, while limiting inflammation by inhibiting macrophage/monocyte phagocytosis and reducing associated chemokine production and oxidative burst.

AB - TGF-β1 (TGF) has been implicated in the pathogenesis of several chronic infections and is thought to promote microbial persistence by interfering with macrophage function. In rats with experimental pulmonary cryptococcosis, increased lung levels of TGF were present at 12 mo of infection. Within the lung, expression of TGF localized to epithelioid cells and foamy macrophages in areas of inflammation. Increased TGF expression was also observed in the lungs of experimentally infected mice and a patient with pulmonary cryptococcosis. TGF reduced Ab and serum-mediated phagocytosis of Cryptococcus neoformans by rat alveolar macrophages (AM) and peripheral blood monocytes, and this was associated with decreased chemokine production and oxidative burst. Interestingly, TGF-treated rat AM limited both intracellular and extracellular growth of C. neoformans. Control of C. neoformans growth by TGF-treated rat AM was due to increased secretion of lysozyine, a protein with potent antifungal activity. The effects of TGF on the course of infection were dependent on the timing of TGF administration relative to the time of infection. TGF treatment of chronically infected rats resulted in reduced lung fungal burden, while treatment early in the course of infection resulted in increased fungal burden. In summary, our studies suggest a dual role for TGF in persistent fungal pneumonia whereby it contributes to the local control of infection by enhancing macrophage antifungal efficacy through increased lysozyme secretion, while limiting inflammation by inhibiting macrophage/monocyte phagocytosis and reducing associated chemokine production and oxidative burst.

UR - http://www.scopus.com/inward/record.url?scp=27744517813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744517813&partnerID=8YFLogxK

M3 - Article

C2 - 16272332

AN - SCOPUS:27744517813

VL - 175

SP - 6757

EP - 6763

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -